Share

Tobacco Control Press Releases

April 26, 2022

Nation’s Leading Cancer Advocacy Organization Urges Washington County Voters to Uphold Flavored Tobacco Law on May Primary Ballot

As ballots are mailed out starting Wednesday, April 27, the American Cancer Society Cancer Action Network (ACS CAN) urges Washington County voters to protect youth from Big Tobacco by voting “no” on Measure 34-314, which would repeal the county’s ordinance to end the sale of all flavored tobacco products. Last year, Washington County became the first county in Oregon to end the sale of flavored tobacco, and now the tobacco industry is funding the campaign to try and overturn this law.

April 19, 2022

Brunswick Town Council Votes to End the Sale of All Flavored Tobacco Products

Today, the Brunswick Council voted unanimously to end the sale all flavored tobacco products, including e-cigarettes and menthol flavored products. The American Cancer Society Cancer Action Network (ACS CAN) applauds Town Council members for prioritizing the health of children and historically marginalized communities over Big Tobacco’s interests and bottom line.

April 15, 2022

District Judge Rules FDA Must Provide Status Reports on Premarket Tobacco Product Applications

Today United States District Judge Paul W. Grimm ruled in American Academy of Pediatrics et al v FDA that beginning on April 29 and every 90 days thereafter, the Food and Drug Administration (FDA) must provide regular status reports to the court and the public on the percentage of premarket tobacco product applications (PMTA) the FDA expects to have acted on by June 2022, and beyond.

March 14, 2022

Arizona Cancer Advocates Rally at Capitol for Increased Access to Innovative Testing and Lifesaving Treatments

American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Arizona rallied at the State Capitol Monday to urge lawmakers to pass legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients.